Tech Company Financing Transactions
NeuShen Therapeutics Funding Round
On 10/3/2022, NeuShen Therapeutics received $20 million in Series A funding from Lapam Capital.
Transaction Overview
Company Name
Announced On
10/3/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Lapam Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand the team and catalyze in-house CNS drug discovery in both the US and China.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
P.R.China: A1023 room, No.1077 Zhangheng Road
Shanghai, Undisclosed
CN
Shanghai, Undisclosed
CN
Phone
Undisclosed
Website
Email Address
Overview
NeuShen was founded to create a steady innovative pipeline of new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joan Shen
Co-Founder
Mike Poole
Co-Founder
Lingyun Wu
Co-Founder
Chao Zhang
Browse more venture capital transactions:
Prev: 10/3/2022: Kahani venture capital transaction
Next: 10/3/2022: Ownly venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs